Identification and Characterization of Metastasis‐Initiating Cells in ESCC in a Multi‐Timepoint Pulmonary Metastasis Mouse Model

• Published in: Advanced science Vol. 11; no. 30; pp. e2401590 - n/a
• Main Authors: Wong, Ching Ngar, Zhang, Yu, Ru, Beibei, Wang, Songna, Zhou, Hongyu, Lin, Jiarun, Lyu, Yingchen, Qin, Yanru, Jiang, Peng, Lee, Victor Ho‐Fun, Guan, Xin‐Yuan
• Format: Journal Article
• Language: English
• Published: Weinheim John Wiley & Sons, Inc 01.08.2024; John Wiley and Sons Inc; Wiley
• Subjects: Biomarkers; early cancer metastasis; early metastasis microenvironment; Esophageal cancer; esophageal squamous cell carcinoma; Flow cytometry; Genes; Lungs; Metastasis; metastasis biomarkers; metastasis‐initiating cells; Mortality; multiplex staining; Oxidative stress; single‐cell transcriptome sequencing; Tumors
• ISSN: 2198-3844; 2198-3844
• DOI: 10.1002/advs.202401590

Metastasis is the biggest obstacle to esophageal squamous cell carcinoma (ESCC) treatment. Single‐cell RNA sequencing analyses are applied to investigate lung metastatic ESCC cells isolated from pulmonary metastasis mouse model at multiple timepoints to characterize early metastatic microenvironment. A small population of parental KYSE30 cell line (Cluster S) resembling metastasis‐initiating cells (MICs) is identified because they survive and colonize at lung metastatic sites. Differential expression profile comparisons between Cluster S and other subpopulations identified a panel of 7 metastasis‐initiating signature genes (MIS), including CD44 and TACSTD2, to represent MICs in ESCC. Functional studies demonstrated MICs (CD44high) exhibited significantly enhanced cell survival (resistances to oxidative stress and apoptosis), migration, invasion, stemness, and in vivo lung metastasis capabilities, while bioinformatics analyses revealed enhanced organ development, stress responses, and neuron development, potentially remodel early metastasis microenvironment. Meanwhile, early metastasizing cells demonstrate quasi‐epithelial‐mesenchymal phenotype to support both invasion and anchorage. Multiplex immunohistochemistry (mIHC) staining of 4 MISs (CD44, S100A14, RHOD, and TACSTD2) in ESCC clinical samples demonstrated differential MIS expression scores (dMISs) predict lymph node metastasis, overall survival, and risk of carcinothrombosis. CD44, TACSTD2, S100A14, and RHOD act as signatures to represent cancer‐spreading‐initiating cells in esophageal squamous cell carcinoma. These cells acquire both mobile and stational properties that flavor spreading and anchorage. High signature score predicts poor patient clinical outcomes, including worsen overall survival, increased risk of cancer‐spreading in lymph node, and increased risk of blood vessel blockage by spreading cancer cells.